Relay Therapeutics, Inc. (RLAY)
NASDAQ: RLAY · IEX Real-Time Price · USD
8.59
-0.01 (-0.17%)
Jul 22, 2024, 11:55 AM EDT - Market open
Relay Therapeutics Market Cap
Relay Therapeutics has a market cap or net worth of $1.14 billion as of July 22, 2024. Its market cap has decreased by -16.83% in one year.
Market Cap
1.14B
Enterprise Value
441.57M
1-Year Change
-16.83%
Ranking
Category
Stock Price
$8.59
Market Cap Chart
Since July 16, 2020, Relay Therapeutics's market cap has decreased from $3.05B to $1.14B, a decrease of -62.60%. That is a compound annual growth rate of -21.74%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 19, 2024 | 1.14B | -15.89% |
| Dec 29, 2023 | 1.36B | -24.86% |
| Dec 30, 2022 | 1.81B | -45.56% |
| Dec 31, 2021 | 3.32B | -11.28% |
| Dec 31, 2020 | 3.74B | 22.82% |
View and export this data all the way back to 2020.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Establishment Labs Holdings | 1.25B |
| Ocular Therapeutix | 1.22B |
| Xencor | 1.18B |
| AtriCure | 1.17B |
| Maravai LifeSciences Holdings | 1.15B |
| Artivion | 1.14B |
| Owens & Minor | 1.13B |
| Autolus Therapeutics | 1.13B |